Aria Diagnostics’ new Patient Advocacy Program simplifies lab billing by providing upfront cost estimates, zero-interest payment plans, and dedicated support. Having a person who will connect with my ...

Phase 2 clinical study protocol submitted; Small Phase 2 study designed to support regulatory interactions and potential ...

Contributor content. Learn more about Into Action Recovery AZ, a men-only addiction program that is different from the ...

Central Texas College is celebrating 30 graduates of its Certified Clinical Medical Assistant (CCMA) program at the Marble ...

The Independent Data Monitoring Committee (IDMC) recommended continuation of the global Phase II PoC study in patients with active pulmonary sarcoidosis without changes to the current protocol.The ...

Bryan College announced the appointments of Nicki Chitwood and Abigail Brown as members of its Business Department faculty. Ms. Chitwood is pursuing a doctorate in Strategic Leadership from ... more ...

RESTORE-FA trial modifications build on positive four-week data; expect to share data based on 12 weeks of dosing in the first quarter of 2027 Patient dosing initiated in Phase 1 multiple-ascending ...

Rocket Pharmaceuticals, Inc. (Rocket or the Company) (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and devastating diseases, focused ...

Milestone Advances Ampligen® Toward Key Clinical Benefit Readout in December 2026 and Overall Survival Analysis in Mid-2027 ...

EAST PALESTINE, Ohio – Insight Clinical Counseling & Wellness LLC has awarded its fourth Youngstown State University ...

California Teen Center has expanded its Intensive Outpatient Program (IOP) for adolescents aged 12-17 struggling with ...

Seaport Therapeutics, Inc., (Nasdaq: SPTX) (“Seaport” or the “Company”), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced ...